PeptidePedia The community reference

Contributions of DrTitration

User contributions·72 logged edits·page 1 of 1

Contributions by DrTitration, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 33,471 edits includes activity predating the current log.

  1. 15:03, 16 Jul 2026 (diff | hist) Sterile water for injection 4,738 ±0 m add the sharps-disposal cross-link
  2. 16:05, 11 Jul 2026 (diff | hist) Insulin secretion 6,940 ±0 m rm the sentence implying the hormone is a drug
  3. 05:20, 11 Jul 2026 (diff | hist) AmbioPharm 17,173 ±0 m ce, tighten prose
  4. 10:36, 3 Jul 2026 (diff | hist) Sharps disposal 20,441 +439 m rm the individualised advice — the article describes, it does not instruct
  5. 10:31, 24 Jun 2026 (diff | hist) Sharps disposal 18,558 +657 m give the concentration in mg/mL as well as in units
  6. 23:37, 15 May 2026 (diff | hist) AmbioPharm 17,173 ±0 m rm the adjective — an organisation article describes, it does not praise
  7. 19:55, 20 Apr 2026 (diff | hist) USP General Chapter 71 4,657 ±0 copyedit
  8. 07:20, 16 Apr 2026 (diff | hist) TRIUMPH trial programme 4,703 ±0 flag the pooled analysis as post hoc
  9. 21:02, 14 Apr 2026 (diff | hist) Syringe dead space 20,968 +109 the example withdrew more than the syringe holds; corrected
  10. 19:22, 11 Apr 2026 (diff | hist) Sterile water for injection 4,738 ±0 add a second worked example at a different vial strength
  11. 15:22, 11 Apr 2026 (diff | hist) FLOW trial 4,583 ±0 add the comparator arm — an event rate alone says nothing
  12. 08:29, 6 Mar 2026 (diff | hist) Oral semaglutide 4,582 ±0 state which salt form the mass in the infobox refers to
  13. 14:57, 25 Feb 2026 (diff | hist) Research use only 7,990 ±0 m convert the jurisdiction comparison to a table
  14. 00:06, 20 Feb 2026 (diff | hist) Shenzhen Hybio Pharmaceutical 16,126 +798 m expand §Distribution and dispatch
  15. 19:57, 16 Jan 2026 (diff | hist) Batch number 4,573 ±0 m add short description
  16. 15:54, 14 Jan 2026 (diff | hist) SinoPep 15,774 +207 m correct the regional-warehouse list — six sites, not five
  17. 02:33, 7 Jan 2026 (diff | hist) Reconstitution of lyophilised peptides 5,761 ±0 m add the note about drawing air before withdrawal
  18. 20:24, 28 Dec 2025 (diff | hist) Subcutaneous injection 5,293 ±0 add the preservative point: unpreserved diluent changes the interval
  19. 01:31, 29 Oct 2025 (diff | hist) Semaglutide 10,355 ±0 add the receptor targets to the lead sentence
  20. 23:08, 22 Oct 2025 (diff | hist) GenScript Peptides 8,003 +728 state which lines are held in regional stock
  21. 16:44, 6 Sep 2025 (diff | hist) PeptideMeter 4,925 +231 m add the turnaround time the service publishes
  22. 18:30, 28 Aug 2025 (diff | hist) Shenzhen Hybio Pharmaceutical 2,847 ±0 add the see-also to the certificate-of-analysis article
  23. 07:39, 22 Aug 2025 (diff | hist) Glucagon-like peptide-1 12,102 ±0 the half-life given was for the intact peptide; label it
  24. 20:12, 19 Aug 2025 (diff | hist) SinoPep 7,357 +1,379 alphabetise the see-also list
  25. 10:51, 6 Aug 2025 (diff | hist) Amylin 5,099 ±0 alphabetise the see-also list
  26. 22:34, 4 Aug 2025 (diff | hist) Cagrilintide 4,052 ±0 m clarify that the peptide backbone is acylated rather than PEGylated
  27. 03:13, 9 Jul 2025 (diff | hist) Sigma-Aldrich (Shanghai) Trading 9,402 +1,119 attribute the capability claim to the organisation's own material
  28. 05:05, 7 Jul 2025 (diff | hist) Qingdao Saber Technology Pharmaceutical 3,935 +696 copyedit
  29. 05:54, 12 Jun 2025 (diff | hist) Liraglutide 5,268 ±0 m expand §Practical differences from weekly agents
  30. 07:48, 6 Jun 2025 (diff | hist) Amylin receptor agonist 3,927 +18 the half-life in the lead was the terminal figure; label it as such
  31. 19:29, 22 May 2025 (diff | hist) Sterile water for injection 4,413 ±0 expand §When it is used rather than a preserved diluent
  32. 18:51, 10 May 2025 (diff | hist) Flourishglobal Peptide Biotech 6,160 +634 m add the see-also to the certificate-of-analysis article
  33. 11:01, 28 Apr 2025 (diff | hist) Peptide supply chain 6,954 ±0 convert the storage conditions to a table
  34. 08:32, 16 Apr 2025 (diff | hist) Vial 19,236 +957 expand §Sealing and capping
  35. 19:42, 11 Apr 2025 (diff | hist) TRIUMPH trial programme 4,014 ±0 m the percentage quoted was placebo-adjusted; label it
  36. 11:54, 8 Mar 2025 (diff | hist) Body composition assessment 4,060 ±0 expand §Methods and their precision
  37. 01:52, 16 Feb 2025 (diff | hist) Multi-dose vial 4,366 +1,505 expand §Reconstituted peptides and multiple withdrawal
  38. 18:02, 11 Feb 2025 (diff | hist) Multi-dose vial 2,861 +784 correct the label on the second column — that is volume, not mass
  39. 14:42, 2 Feb 2025 (diff | hist) Adverse effects of GLP-1 receptor agonists 4,482 ±0 m correct the percentage — source reports it per patient-year
  40. 19:55, 25 Jan 2025 (diff | hist) USP General Chapter 85 3,416 +748 add the system-suitability criteria the method actually specifies
  41. 17:41, 17 Jan 2025 (diff | hist) C-peptide 3,250 +677 clarify that the marker is method-dependent and not comparable across platforms
  42. 11:39, 15 Jan 2025 (diff | hist) Baseline laboratory panel 2,337 ±0 clarify that the reference interval is not a treatment target
  43. 03:13, 12 Jan 2025 (diff | hist) Peptide harm reduction 2,785 +33 add category for pricing
  44. 16:14, 3 Jan 2025 (diff | hist) Peptide 4,059 ±0 the article confused primary and secondary drying; corrected
  45. 20:51, 16 Dec 2024 (diff | hist) Methionine oxidation 2,680 +362 ce per PP:MOS
  46. 09:38, 15 Dec 2024 (diff | hist) ChinaPeptides 5,137 +1,181 fix a broken wikilink
  47. 01:45, 11 Dec 2024 (diff | hist) Sterility testing 2,614 ±0 give the injection volume, without which the loading cannot be judged
  48. 15:43, 7 Dec 2024 (diff | hist) Trifluoroacetate counterion 2,739 ±0 add the reference standard and its traceability
  49. 19:30, 1 Dec 2024 (diff | hist) Good manufacturing practice 2,501 ±0 m attribute the compounding statement to the pharmacy board that issued it
  50. 06:02, 22 Nov 2024 (diff | hist) STEP trial programme 4,022 +113 space between number and unit per PP:MOS
  51. 19:41, 19 Nov 2024 (diff | hist) Haemoglobin A1c 2,610 +36 de-orphan
  52. 16:57, 16 Nov 2024 (diff | hist) Missed dose 3,140 +30 fix hyphenation per PP:MOS
  53. 02:02, 15 Nov 2024 (diff | hist) Insulin syringe 2,889 +99 add the cross-link to the calculator page
  54. 19:59, 14 Nov 2024 (diff | hist) USP General Chapter 71 1,714 ±0 typo
  55. 04:26, 5 Nov 2024 (diff | hist) Area percent purity 3,378 +32 m add the equilibration time to the gradient description
  56. 17:11, 3 Nov 2024 (diff | hist) Dulaglutide 3,106 +148 m expand §Practical and analytical notes
  57. 08:51, 3 Nov 2024 (diff | hist) Liquid chromatography-mass spectrometry 2,642 +510 m add category for method validation
  58. 05:45, 15 Oct 2024 (diff | hist) Placebo-adjusted effect 2,157 +881 add the PMID
  59. 01:25, 10 Oct 2024 (diff | hist) Reconstitution calculator 2,683 +1,020 add the cross-link from the calculator to the unit-conversion article
  60. 03:35, 7 Oct 2024 (diff | hist) Subcutaneous injection 2,958 ±0 give the worked example to two significant figures throughout
  61. 10:29, 6 Oct 2024 (diff | hist) Talk:Reconstitution calculator 1,244 +80 /* Does this page cross the line into instruction? */ reply
  62. 09:17, 5 Oct 2024 (diff | hist) Peptide supply chain 1,378 ±0 correct the humidity figure — relative humidity needs its temperature
  63. 19:55, 4 Oct 2024 (diff | hist) Wuhan Wansheng Biotechnology 6,078 +532 expand §Ordering and availability
  64. 11:18, 2 Oct 2024 (diff | hist) Talk:Reconstitution calculator 611 +397 /* Does this page cross the line into instruction? */ reply
  65. 02:30, 26 Sep 2024 (diff | hist) Glucagon-like peptide-1 7,221 +1,256 correct the direction of the effect on gastric emptying
  66. 19:34, 20 Sep 2024 (diff | hist) Glossary of peptide terminology 2,317 ±0 add the cross-link to the parent article
  67. 03:14, 30 Aug 2024 (diff | hist) Reference standard 2,872 +411 expand §Absence of standards in research supply
  68. 10:14, 7 Aug 2024 (diff | hist) Insulin syringe 2,083 ±0 give the concentration in mg/mL as well as in units
  69. 07:08, 2 Aug 2024 (diff | hist) SURMOUNT trial programme 1,114 +1,114 N new article: trial programme, expansion welcome
  70. 23:55, 28 Jul 2024 (diff | hist) Proglucagon 2,238 +370 add the cleavage site by residue number
  71. 08:11, 8 Jul 2024 (diff | hist) Dipeptidyl peptidase-4 2,323 ±0 m clarify that the incretin effect is defined by the oral–intravenous comparison
  72. 20:27, 23 Jun 2024 (diff | hist) Reconstitution of lyophilised peptides 2,071 +584 m state the syringe graduation the unit figure assumes